C07K 7/18
Kallidins
Official title: Kallidins; Bradykinins; Related peptides
C07K7/18 (Kallidins) appears on 107 US grants and 56 published applications in this corpus.
Search patents in C07K- Granted patents
- 107
- Published applications
- 56
- Assignees
- 64
- Inventors
- 227
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 5 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 6 | 0 |
| 1996 | 7 | 0 |
| 1997 | 12 | 0 |
| 1998 | 9 | 0 |
| 1999 | 7 | 0 |
| 2000 | 3 | 0 |
| 2001 | 6 | 1 |
| 2002 | 3 | 3 |
| 2003 | 0 | 4 |
| 2004 | 2 | 4 |
| 2005 | 1 | 3 |
| 2006 | 6 | 4 |
| 2007 | 2 | 1 |
| 2008 | 1 | 2 |
| 2009 | 1 | 6 |
| 2010 | 4 | 2 |
| 2011 | 3 | 4 |
| 2012 | 4 | 5 |
| 2013 | 1 | 2 |
| 2014 | 2 | 1 |
| 2015 | 0 | 2 |
| 2016 | 2 | 2 |
| 2017 | 0 | 1 |
| 2018 | 4 | 2 |
| 2019 | 2 | 2 |
| 2020 | 1 | 1 |
| 2021 | 0 | 2 |
| 2022 | 2 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for treating inflammation using antibodies to kallidin and des-Arg10-kallidin24 Feb 2026US 12,558,420 B2Sanofi
- Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof2 Aug 2022US 11,401,303 B2Taian City Qihang Biotechnology Co.
- Kinin-based theranostic probes for solid cancers and uses thereof4 Jan 2022US 11,213,597 B2SociéTé De Commercialisation Des Produits De La Recherche AppliquéE Socpra Sciences Santé Et Humaines S.E.C.
- Therapeutic fusion proteins7 Jul 2020US 10,704,038 B2Ipsen Bioinnovation Limited
- Nucleic acids encoding antibodies to Kallidin and des-Arg10-Kallidin and host cells comprising the same5 Nov 2019US 10,465,002 B2Sanofi
- Methods for treating inflammation using antibodies to kallidin and des-arg10-kallidin14 Dec 2023US 2023/0399388 A1Sanofi
- Synthetic peptide brap and application in preparation of anti-inflammatory drug for covid-19 thereof12 May 2022US 2022/0144891 A1Taian City Qihang Biotechnology Co.
- Peptide-drug conjugates23 Dec 2021US 2021/0395309 A1Hong Kong Baptist University
- A method for production of high purity icatibant5 Aug 2021US 2021/0238230 A1Fresenius Kabi Ipsum S.R.L.
- Methods for treating inflammation using antibodies to kallidin and des-arg10-kallidin16 Apr 2020US 2020/0115441 A1Sanofi
Most cited
By later US patents
- Increasing blood-brain barrier permeability with permeabilizer peptides176US 5,268,164 AAlkermes, Inc. · 1993
- Increasing blood-brain barrier permeability with permeabilizer peptides149US 5,506,206 AAlkermes, Inc. · 1996
- Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability130US 5,112,596 AAlkermes, Inc. · 1992
- Increasing blood-brain barrier permeability with permeabilizer peptides102US 5,686,416 AAlkermes, Inc. · 1997
- Stem cell immobilization76US 5,912,177 ACommon Services Agency · 1999